uawdijnntqw1x1x1
IP : 18.218.245.238
Hostname : ns1.eurodns.top
Kernel : Linux ns1.eurodns.top 4.18.0-553.5.1.lve.1.el7h.x86_64 #1 SMP Fri Jun 14 14:24:52 UTC 2024 x86_64
Disable Function : mail,sendmail,exec,passthru,shell_exec,system,popen,curl_multi_exec,parse_ini_file,show_source,eval,open_base,symlink
OS : Linux
PATH:
/
home
/
sudancam
/
public_html
/
0d544
/
..
/
..
/
.trash
/
.
/
catalog
/
..
/
..
/
public_html
/
assets
/
..
/
un6xee
/
index
/
ich-q6a-and-q6b.php
/
/
<!DOCTYPE html> <html class="tcb" lang="en"> <head> <!--[if IE 7]> <html class="ie ie7" lang="en"> <![endif]--><!--[if IE 8]> <html class="ie ie8" lang="en"> <![endif]--><!--[if !(IE 7) | !(IE 8) ]><!--><!--<![endif]--> <meta charset="UTF-8"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title></title> <style class="tve_custom_style">@media (min-width:300px){[data-css="tve-u-167332325e7"]{background-color:rgb(239,239,239);border:0px none rgb(91,91,91);border-radius:0px;background-image:none;background-repeat:repeat;background-size:auto;background-attachment:scroll;background-position:0% 0%;box-shadow:none;}[data-css="tve-u-167332325eb"]{padding:20px;color:rgb(51,51,51);min-height:0px;margin-left:0px;margin-right:0px;margin-top:0px;}[data-css="tve-u-167332325f4"]{max-width:1080px;}[data-css="tve-u-167332331bc"]{border-radius:2px;border-width:0px;border-style:none;border-color:rgb(51,51,51);background-color:rgb(78,122,199) !important;background-image:none !important;padding:20px !important;}[data-css="tve-u-167332331bf"]{margin:0px;min-width:100% !important;}[data-css="tve-u-167332331bf"] .tcb-button-link{font-size:36px;box-shadow:none;}:not(#tve) [data-css="tve-u-167332331bf"] .tcb-button-link{font-family:"Open Sans",sans-serif;}:not(#tve) [data-css="tve-u-167332331bf"] .tcb-button-link span{color:rgb(255,255,255);text-shadow:rgb(17,118,193) 0px 1px 0px;}[data-css="tve-u-16733233d46"]{border-radius:2px;border-width:0px;border-style:none;border-color:rgb(51,51,51);background-color:rgb(78,122,199) !important;background-image:none !important;padding:20px !important;}[data-css="tve-u-16733233d47"]{margin-right:0px;margin-bottom:0px;margin-left:0px;min-width:100% !important;margin-top:55px !important;}[data-css="tve-u-16733233d47"] .tcb-button-link{font-size:36px;box-shadow:none;}:not(#tve) [data-css="tve-u-16733233d47"] .tcb-button-link{font-family:"Open Sans",sans-serif;}:not(#tve) [data-css="tve-u-16733233d47"] .tcb-button-link span{color:rgb(255,255,255);text-shadow:rgb(17,118,193) 0px 1px 0px;}[data-css="tve-u-167332348b5"]{border-radius:2px;border-width:0px;border-style:none;border-color:rgb(51,51,51);background-color:rgb(78,122,199) !important;background-image:none !important;padding:20px !important;}[data-css="tve-u-167332348b6"]{margin-right:0px;margin-bottom:0px;margin-left:0px;min-width:100% !important;margin-top:0px !important;}[data-css="tve-u-167332348b6"] .tcb-button-link{font-size:36px;box-shadow:none;}:not(#tve) [data-css="tve-u-167332348b6"] .tcb-button-link{font-family:"Open Sans",sans-serif;}:not(#tve) [data-css="tve-u-167332348b6"] .tcb-button-link span{color:rgb(255,255,255);text-shadow:rgb(17,118,193) 0px 1px 0px;}[data-css="tve-u-16733235417"]{border-radius:2px;border-width:0px;border-style:none;border-color:rgb(51,51,51);background-color:rgb(78,122,199) !important;background-image:none !important;padding:20px !important;}[data-css="tve-u-1673323541a"]{margin-right:0px;margin-bottom:0px;margin-left:0px;min-width:100% !important;margin-top:20px !important;}[data-css="tve-u-1673323541a"] .tcb-button-link{font-size:36px;box-shadow:none;}:not(#tve) [data-css="tve-u-1673323541a"] .tcb-button-link{font-family:"Open Sans",sans-serif;}:not(#tve) [data-css="tve-u-1673323541a"] .tcb-button-link span{color:rgb(255,255,255);text-shadow:rgb(17,118,193) 0px 1px 0px;}:not(#tve) [data-css="tve-u-16a50670896"]{color:rgb(255,0,0) !important;text-transform:uppercase !important;font-size:44px !important;}[data-tve-custom-colour="50153525"]{background-color:rgb(0,60,135) !important;box-shadow:transparent 0px 0px 8px 4px inset,transparent 0px 0px 7px 3px !important;border-color:rgb(91,91,91) !important;}.thrv_header .symbol-section-in,.thrv_footer .symbol-section-in{box-sizing:border-box;}[data-css="tve-u-17da6c86dc7"]{margin-right:0px;margin-bottom:0px;margin-left:0px;min-width:100% !important;margin-top:20px !important;}[data-css="tve-u-17da6c86dc7"] .tcb-button-link{font-size:36px;box-shadow:none;background-image:none !important;--background-image:none!important;--tve-applied-background-image:none!important;background-color:rgb(255,0,0) !important;--background-color:rgb(255,0,0)!important;--tve-applied-background-color:rgb(255,0,0)!important;}:not(#tve) [data-css="tve-u-17da6c86dc7"] .tcb-button-link{font-family:"Open Sans",sans-serif;}:not(#tve) [data-css="tve-u-17da6c86dc7"] .tcb-button-link span{color:rgb(255,255,255);text-shadow:rgb(17,118,193) 0px 1px 0px;}[data-css="tve-u-17da6c86dc9"]{border-radius:2px;border-width:0px;border-style:none;border-color:rgb(51,51,51);background-color:rgb(78,122,199) !important;background-image:none !important;padding:20px !important;}}@media (max-width:1023px){[data-css="tve-u-167332348b6"]{margin-top:24px !important;}[data-css="tve-u-16733233d47"]{margin-top:24px !important;}}@media (max-width:767px){[data-css="tve-u-167332348b6"]{margin-top:32px !important;}[data-css="tve-u-16733233d47"]{margin-top:38px !important;}:not(#tve) [data-css="tve-u-16a50670896"]{font-size:32px !important;}}</style> <style> html { height: auto; } { overflow-y: initial; } body:before, body:after { height: 0 !important; } .thrv_page_section .out { max-width: none } .tve_wrap_all { position: relative; } /* Content Width - inherit Content Width directly from LP settings */ .thrv-page-section[data-inherit-lp-settings="1"] .tve-page-section-in { max-width: 1080px !important; max-width: var(--page-section-max-width) !important; } /* set the max-width also for over content settings */ .thrv_header, .thrv_footer { width: 100vw; max-width: 100vw; left: 50%; right: 50%; margin-left: -50vw !important; margin-right: -50vw !important; } </style> <style type="text/css" class="tve_custom_style">@media (min-width:300px){[data-css="tve-u-167515c9e8e"]{max-width:1000px !important;border-style:none !important;background-color:rgb(255,255,255) !important;border-color:rgb(51,51,51) !important;}[data-css="tve-u-167515c9e9b"]{border-style:inherit !important;background-color:rgba(0,0,0,0) !important;border-color:rgb(98,98,98) !important;color:rgb(98,98,98) !important;border-width:inherit !important;display:none !important;}[data-css="tve-u-167515ccca0"]{background-color:rgb(226,226,226);border:0px none rgb(51,51,51);border-radius:0px;}[data-css="tve-u-167515ccca1"]{padding:0px;}[data-css="tve-u-167515ccca1"] .tve-cb h3{color:rgb(51,51,51);margin-top:60px;margin-bottom:0px;}[data-css="tve-u-167515ccca1"] .tve-cb p{color:rgb(255,255,255);margin-top:0px;margin-bottom:24px;}:not(#tve) [data-css="tve-u-16a5068edfe"]{color:rgb(255,0,0) !important;text-transform:uppercase !important;font-size:23px !important;}:not(#tve) [data-css="tve-u-17306bfaa03"]{padding-top:0px !important;margin-top:0px !important;}[data-css="tve-u-17306bfbe28"]{margin-top:-248px !important;}}</style> <style type="text/css" class="tve_custom_style">@media (min-width:300px){:not(#tve) [data-css="tve-u-16a506a4081"]{color:rgb(255,0,0) !important;text-transform:uppercase !important;font-size:19px !important;}[data-css="tve-u-17306c05ff5"]{background-color:rgba(0,0,0,0.8) !important;}[data-css="tve-u-17306c06005"]{max-width:550px !important;border-style:none !important;background-color:rgb(255,255,255) !important;border-color:rgb(51,51,51) !important;}[data-css="tve-u-17306c0600f"]{border-style:inherit !important;background-color:rgba(0,0,0,0) !important;border-color:rgb(98,98,98) !important;color:rgb(98,98,98) !important;border-width:inherit !important;display:none !important;}:not(#tve) [data-css="tve-u-179f71b3ada"]{padding-top:0px !important;margin-top:0px !important;}}</style> <style type="text/css" class="tve_custom_style">@media (min-width:300px){[data-css="tve-u-17306bdd200"]{max-width:43.5%;}[data-css="tve-u-17306bdd219"]{max-width:56.5%;}[data-css="tve-u-17306bdf9cc"]{width:268px;margin-top:-155px !important;margin-right:105px !important;}[data-css="tve-u-17306bed0c0"]{background-color:rgb(226,226,226);border:0px none rgb(51,51,51);border-radius:0px;}[data-css="tve-u-17306bed0c2"]{padding:0px;}[data-css="tve-u-17306bed0c2"] .tve-cb h3{color:rgb(51,51,51);margin-top:60px;margin-bottom:0px;}[data-css="tve-u-17306bed0c2"] .tve-cb p{color:rgb(255,255,255);margin-top:0px;margin-bottom:24px;}[data-css="tve-u-17306bf1ef1"]{max-width:1000px !important;border-style:none !important;background-color:rgb(255,255,255) !important;border-color:rgb(51,51,51) !important;}[data-css="tve-u-17306bf1efe"]{border-style:inherit !important;background-color:rgba(0,0,0,0) !important;border-color:rgb(98,98,98) !important;color:rgb(98,98,98) !important;border-width:inherit !important;display:none !important;}:not(#tve) [data-css="tve-u-17306bf5c1b"]{padding-top:0px !important;margin-top:0px !important;}}</style> <style type="text/css" class="tve_custom_style">@media (min-width:300px){[data-css="tve-u-17da6e42eef"]{max-width:1000px !important;border-style:none !important;background-color:rgb(255,255,255) !important;border-color:rgba(10,10,10,) !important;padding-bottom:0px !important;padding-top:0px !important;}[data-css="tve-u-17da6e42ef5"]{border-style:inherit !important;background-color:rgba(0,0,0,0) !important;border-color:rgb(98,98,98) !important;color:rgb(98,98,98) !important;border-width:inherit !important;}[data-css="tve-u-17da6e4b51c"]{width:267px;--tve-alignment:center;float:none;margin-left:auto !important;margin-right:auto !important;}[data-css="tve-u-17da6e4d916"]{padding-bottom:0px !important;padding-top:0px !important;}[data-css="tve-u-17db5a38c01"]{max-width:%;}}</style> </head> <body class="home page-template-default page page-id-10 tve_lp" style=""> <br> <div class="tve_wrap_all" id="tcb_landing_page"> <div class="tve_post_lp tve_lp_knowhow-confirmation-page tve_lp_template_wrapper" style=""> <div id="tve_flt" class="tve_flt tcb-style-wrap"> <div id="tve_editor" class="tve_shortcode_editor tar-main-content" data-post-id="10"> <div class="tve_lp_content tve_editor_main_content tve_empty_dropzone tve_content_width"> <div class="thrv_wrapper thrv-page-section tve_empty_dropzone tcb-window-width" data-tve-style="1" data-css="tve-u-167332325eb" style=""> <div class="tve-page-section-out" data-css="tve-u-167332325e7"></div> <div class="tve-page-section-in" data-css="tve-u-167332325f4"> <div class="thrv_wrapper thrv_text_element" data-tag="h1"> <h1 class="" data-css="tve-u-16a50670896" style="text-align: center;"><strong>Ich q6a and q6b. com/thsk4mf/love-marriage-images.</strong></h1> </div> <br> </div> </div> </div> <div class="tve_lp_footer tve_empty_dropzone"> <div class="thrv_wrapper thrv_page_section" data-tve-style="1"> <div class="out" style="background-color: rgb(13, 23, 37);" data-tve-custom-colour="50153525"> <div class="in lightSec"> <div class="cck clearfix tve_empty_dropzone"> <div class="thrv_wrapper thrv_text_element"> <p class="tve_p_center" style="margin: 0pt; padding: 0pt; color: rgb(153, 153, 153); font-size: 17px;"><font color="#ffffff">Ich q6a and q6b. , conjugates). MaV, MiV, G: Các quy định trong dược điển hoặc thông tin tương đương từ nhà sản xuất. 18 July 1997 Q6A Current Step 4 version Q6A Approval by the Steering Committee under Step 4 and recommendation for adoption to the three ICH regulatory bodies. ICH. no CPMP/ICH/367/96 ICH Topic Q 6 A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Step 5 NOTE FOR GUIDANCE SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW DRUG SUBSTANCES AND NEW DRUG PRODUCTS: CHEMICAL SUBSTANCES (CPMP/ICH/367/96) ICH Guideline Content: With this guideline on specifications and testing methods of new active substances and medicinal products ICH intends to make possible the compilation of a single specification valid worldwide for new active substances and new finished medicinal products. An impurity less often repo … The presence of impurities or contaminants in biological products such as monoclonal antibodies (mAb) could affect efficacy or cause adverse reactions in patients. its composition should be provided. The use of two decimal places for thresholds (See . DEVELOPING SPECIFICATION FOR DRUG SUBSTANCE AND DRUG PRODUCT AS PER ICH Q6A Q6B AND Q3 (A )AND Q3 (C ) 1. Since its inception in 1990, ICH has gradually evolved, to ICH Q2A and Q2B Guidelines for Analytical Validation). 1 Manufacturer(s) Name and full addresses including the city and country of the manufacturer of active ingredient. USE. To product using the principles of risk management as described in ICH Q9. 1002/9781118971147. STABILITY DATA Stability data occupy a central role in the process of determining expiry limits, shelf life, and release limits. Tham khảo Hướng dẫn ICH: NCE: Q2A; Biotech: Q6B. 2, a Critical Quality Attribute (CQA) is ‘ a physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality ’. Q6A . Center for Drug 详见ich指导原则“新药制剂杂质”和“药品中的残留溶剂”。 新原料药降解产生的有机杂质和该制剂在生产过程中产生的杂质均应在新药制剂中检测。 应对单个的特定的降解产物(包括已鉴定的和未鉴定的)及总的降解产物的限度进行规定。 Jun 30, 2018 · ICH Q6A ICH Q6B. Q6A: Approbation par le Comité directeur dans le cadre de l'étape 2 et publication à des fins de consultation publique. It applies to drug substances produced by chemical syntheses and not previously registered in a region or Member State. A separate ICH Guideline, ”Specifications:Test Procedures and Acceptance Criteria for New Drugs Substances and New Drug Products: Chemical Substances” addresses specifications, and other criteria for chemical substances. This approach applies equally for the ICH Q6B Dec 2, 2017 · 在ich“新药制剂 杂质”指导原则中有详细说明。 2. q9_quality risk management q10_pharmaceutical quality system [/sociallocker] 40 1. 6 octobre 1999: Q6A ologics control strategy are established. 1 General Principles The design and execution of formal stability studies should follow the principles example, the ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances describes some of the circumstances in which drug product studies are recommended (e. ICH Q6B primarily applies to new drug substances and drug products, including well-established use products. Q3B(R2) Impurities in New Drug Products. 12. Jan 29, 2016 · Q6A: Approval by the Steering Committee under Step 2 and release for public consultation. EMA/531552/2023 Page 5/18 Annex 1. S. This Guideline has been developed by the appropriate ICH Expert Working Group and GUIDELINE FOR GOOD CLINICAL PRACTICE. 1 Periodic/Skip Testing Performance of specified tests at release on pre-selected batches and/or at predetermined intervals. Office of Training and Communications Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857 (Tel) 301-827 whole blood, and cellular blood components. David P Elder Consultancy. Mar 4, 2020 · Developing specifications q3 q6. 5. Q6A Document History First Codification History Date New Codification November 2005 Q6A Approval by the Steering Committee under Step 2 and release for public consultation. Examples for solid dosage forms: • dissolution ocod@fda. 4, Sect. In book: ICH Quality Guidelines (pp. g. Office of Communication, Training and Manufacturers Assistance, HFM-40 Center for Biologics Evaluation and Research Food and Drug Administration 1401 Rockville Pike, Rockville, MD 20852-1448 Streamlining ICH Q6B Analytical Testing of Biotherapeutics 393 mapping techniques so that the site of oxidation can be determined and the peptide map optimized to resolve the variant peptides. It is often possible to force degradation of the drug using accelerated stability or degradatio n pathway studies where the drug is stressed Apr 18, 2017 · Tham khảo Hướng dẫn ICH: NCE: Q6A; Biotech: Q6B. The ICH Q6A guidance contains various decision trees aimed at helping applicants navigate the various Content: These attachments contain decision trees and provide additional guidance on how specifications should be set for testing of drug substances and dosage forms and on when, and how various tests should be performed. This process provides a platform for developing a risk-based control strategy to limit elemental impurities in the drug product. Sep 7, 2016 · The presence of impurities or contaminants in biological products such as monoclonal antibodies (mAb) could affect efficacy or cause adverse reactions in patients. The ICH Q6A guidance contains various decision trees aimed at helping applicants navigate the various Dec 14, 2018 · In this paper, we remind readers of several ICH guideline documents such as ICH Q3A, Q3B, Q3C, Q3D, Q6A, Q6B, M7, and ICH S9 which are related to the drug substance and drug product impurity limit setting. The guideline will not cover regional prerequisites for postapproval changes (ICH Q11, 2011). 2 Description of Manufacturing Process and Process Controls The description of the drug substances manufacturing process represents the applicant’s Protein characterization and protein analysis services in line with ICH Q6B guidance, including structure and sequence protein analytics, physicochemical properties, biological activity, immunochemical properties and purity, and impurities determination. S. Phải cung cấp quy trình phân tích dùng để thử các tá dược, khi thích hợp. SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW DRUG SUBSTANCES AND NEW DRUG PRODUCTS: CHEMICAL SUBSTANCES. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Mit dieser Leitlinie über Spezifikationen und Prüfungsmethoden neuer Wirkstoffe und Arzneimittel beabsichtigt die ICH, zukünftig die Erstellung einer einzigen, weltweit gültigen Spezifikation für neue Wirkstoffe bzw. Introduction Objective Scope General Concepts Guidelines Specifications: Definition. hhs. Scope of the. Apart from the standard ICH guidelines, nowadays, the patient-centric approach is the more ICH guidelines (Q6A and Q6B) are in place to regulate the level of impurities within clinical drug products. Objective of the. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN. These proteins and polypeptides are produced from recombinant or nonrecombinant cell-culture expression systems and can be highly purified and characterized using an harmonisation efforts at ICH meetings as appropriate. Pustaka: Pedoman ICH Q2A, Q2B, Q6A dan Q6B. 1. DOI: 10. i Both guidelines (Q6A and Q6B) distinguish between Universal Tests, which are required in any new specification for a new drug substance or drug product, and Specific Tests, which should be determined, on a case-by-case basis, depending Nov 17, 2017 · Q6 guidelines - Download as a PDF or view online for free. However, little is known about This guidance document provides guidance on general principles for the setting and justification of a uniform set of international specifications for biotechnological and … ICH Q6A and Q6B should be consulted for recommendations on the setting and justification of acceptance criteria, and ICH Q1D should be referenced for recommendations on the use of full- versus reduced-design studies. B:Q6B指导原则适用于蛋白质、多肽及其衍生物和含有这些成分的产品,这些蛋白质和多肽由基因重组或非重组工程细胞培养表达系统生产,可被高度纯化,并可用一套适宜 Sep 12, 2019 · Health risks associated with (1 → 3)-β-D-glucan contamination in pharmaceutical products were discussed at the Parenteral Drug Association annual meeting in 2017. 4. Jan 1, 2013 · ICH has issued two consensus guidance documents entitled “Specifications: Test Procedures and Acceptance Criteria”; one is specific for chemical drugs (ICH Q6A) and the other is specific for biological products (ICH Q6B). 2. A:Q6B的适用范围是什么?. TABLE OF CONTENTS. 18 July 1997: Q6A: Current Step 4 version; Q6A: Approval by the Steering Committee under Step 4 and recommendation for adoption to the three ICH regulatory bodies. 1 of 61. It covers chemistry and safety aspects of impurities in new drug substances. The information provided should include: Description of the dosage form; Composition, Function of the components, and a. Sep 27, 2017 · The International Conference on Harmonisation (ICH) Q6B document provides guidance for establishing specifications applicable to commercial biological products but specifies in the scope that it does not “apply to the regulation of preclinical and/or clinical research material”. Since its inception in 1990, ICH has gradually evolved, to Guidance for Industry. 6: 有: Q6B: Specifications: Test Procedures and Acceptance Criteria The International Conference on Harmonisation (ICH) Q6A guideline indicates that specifications form part of the overarching control systems that help to assure the quality of the API and drug product at release and at the end of shelf life. example, the ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances describes some of the circumstances in which drug product studies are recommended (e. September 2017. Q6B(ステップ5) Jan 1, 2014 · According to ICH Q6A, a specification (singular) contains three elements: a list of tests (or attributes), references to test methods and acceptance criteria. 6 (ICH M4Q). ICH Press Release. 10. include: Description of the dosage form; Dec 29, 2000 · The Food and Drug Administration (FDA) is publishing a guidance entitled ``Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. dated 6 October 1999 . Jan 8, 2002 · guideline. Assembly. Technical factors (e. 2 Quy trình phân tích. q7_good manufacturing practice guide for active pharmaceutical ingredients. This guideline is applicable to drug substances as defined in the Scope sections of ICH Guidelines Q6A and Q6B, but might also be appropriate for other types of products following consultation with the appropriate regulatory authorities. Q14Analytical Procedure Development guideline substances as defined in the Scope sections of the ICH Q6A and Q6B guidances, but might also be appropriate for other types of products following consultation with the appropriate regulatory This paper provides a new computational method for determining shelf life, expiry limits, and release limits using random slopes based upon Least Squares ANOVA Estimators. . Statement of the Perceived Problem . In particular, ICH Q6A clearly states that “specifications should focus on those characteristics found to be useful in ensuring the safety and efficacy of the drug substance and drug Dec 11, 2018 · Setting of specification limits as per ICH Q6A. Scope . 3. 5 Validasi Proses dan/atau Laporan Uraian, dokumentasi, dan hasil studi validasi dari tahapan kritis atau penentuan kadar kritis yang dilakukan pada proses pembuatan harus diserahkan (Contohnya, validasi proses ICH Q6A and Q6B should be consulted for recommendations on the setting and justification of acceptance criteria, and ICH Q1D should be referenced for recommendations on the use of full- Feb 25, 2020 · Pharmaceutical industries are using various guidelines such as ICH Q6A, Q6B, Q3 as well as clinical safety data for setting specifications for impurities in drug products including a pharmacological approach based on biological activity and toxicity, etc. ICH Q6A C 104 2. PREAMBLE ICH: quality. Continued ICH Growth and Advancement. A description of the drug product and its composition should be provided. This chapter discusses the principles to be considered in As detailed in ICH Q12, this includes the use of: • Post-approval change … ranges, or other criteria for the tests described (ICH Q6A/Q6B). '' The guidance was prepared under the auspices of the International Conference on Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 7 February 2002, this guideline is recommended for adoption to the three regulatory parties to ICH. 2. Electronic Standards (ESTRI) Reflection Papers & Discussion Groups. Periodic or Skip Testing Periodic or skip testing is the performance of specified tests at release on pre-selected batches and / or at predetermined intervals, rather than on a batch-to-batch basis with the understanding that those batches not being tested still must meet all acceptance criteria established for that product. It describes the general concepts that are critically important in the development of harmonized specifications, with the caveat that true The scope of this Q&A document follows that of ICH Q11. EMA/531552/2023 Nov 6, 2023 · A Patient-Centric Review of ICH Q6A and Q6B (PART I) According to ICH Q6, specifications are “a list of tests, references to analytical procedures, and appropriate acceptance criteria which are numerical limits, ranges, or other criteria for the tests described. It is particularly relevant to the preparation and organisation of the Jul 28, 2018 · ICH. Protein characterisation can present complex challenges for drug development. Nov 16, 2022 · Q6A- Q6B Specifications/规格: Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances : Q6A:质量标准:新原料药和新药制剂的检测方法和可接受标准:化学药物: 阶段5: 1999. Critical quality attributes (CQAs) define the needed product quality. Sep 27, 2017 · The International Conference on Harmonisation (ICH) Q6A guideline indicates that specifications form part of the overarching control systems that help to assure the quality of the API and drug product at release and at the end of shelf life. Jan 7, 1996 · ICH Q1B Photostability testing of new active substances and medicinal products; ICH Q1C Stability testing: requirements for new dosage forms; ICH Q1D Bracketing and matrixing designs for stability testing of drug substances and drug products; ICH Q1E Evaluation of stability data; ICH Q1F Stability data package for registration in climatic zones Reference ICH Guidelines: NCE : Q6A, Biotech : Q6B S 2 Manufacture S 2. May 31, 2017 · q6b_specifications – test procedures and acceptance criteria for biotechnological_biological products. In addition, specification for degradation products in a drug product is addressed in Q3B. Since its inception in 1990, ICH has gradually evolved, to Feb 21, 2023 · ICH Guidelines는 크게 4가지 파트로 나눠 집니다. ICH guidelines (Q6A and Q6B) are in place to regulate the level of impurities within clinical drug products. ch16. Q6A. Quality Guidelines (품질가이드라인) 품질 기준의 조화를 이루기 위하여 예를 들면 안정성 시험, 불순물시험에 기준점 정하는 법 (relevant thresholds) 그리고 GMP 위험 관리에 의거한 의약품 품질의 유연한 접근성을 Jan 1, 2022 · The guidance is relevant to drug substances that are distinct in the limits of ICH Guidelines Q6A and Q6B. DEVELOPING SPECIFICATION PRESENTEDBY : NAMRATA BAWASKAR M PHARM (QA) SUBJECT : QUALTY CONTROL QUALITY ASSURANCE ALL INDIA SHRI SHIVAJI MEMORIAL SOCIETY’S COLLEGE OF PHARMACY ,PUNE. ICH Q6A and Q6B should be consulted for recommendations on the setting and justification of acceptance criteria, and ICH Q1D should be referenced for recommendations on the use of full- versus reduced-design studies. The meeting was preceded by virtual meetings of the ICH Management Committee and MedDRA The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. S 2. A description of the drug product and. The process starts with consideration of the new topic and development of a consensus by the relevant Expert Working Group (EWG). 18 juillet 1997: Q6A: Version la plus récente de l'étape 4; Q6A: Approbation par le Comité directeur dans le cadre de l'étape 4 et adoption recommandée aux trois organismes de réglementation de l'ICH. ICH Calendar. However ICH Q6B and ICH Q6A2 do not provide specific guidance for FIH-stage biologic specifications. ICH Q6A SPECIFICATIONS By,CHANDRAMOHAN. reference to their quality standards Type of container and closure used. 11 对照品 对照品或参比物质系指在含量测定、鉴别、纯度试验中作为标准品的物质。 它应具有与 其用途相适应的质量要求,常通过增加常规试验以外的方法来检验和评价。 Aug 10, 2005 · 1. Description and Composition of the Drug The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. ICH Q11 is applicable to drug substances as defined in the Scope sections of the ICH Q6A and Q6B guidelines, but might also be appropriate for other types of products following consultation with the appropriate regulatory authorities. P3. CIOMS Glossary of ICH Terms & Definitions. ICH HARMONISED TRIPARTITE GUIDELINE. Consideration Documents. This document provides guidance on the content and qualification of impurities in new drug substances for registration applications. 4. This provides an excellent opportunity to update ICH Q6A/B to align and work in a complementary manner with the science-, risk/knowledge-based concepts in ICH Q8–Q12. ”. Since most analytical properties have the potential to change over time, it is necessary to estimate the change and account for the uncertainty of estimation. The EWG members are nominated from the regulatory and industrial 3. 433-466) Authors: David P Elder. Current Step 4 version. Download now. • Addresses a consistent need for interpretation, training, and implementation examples of ICH guidelines via case studies• Offers a Produk Antara: Informasi mutu dan kontrol produk antara selama proses pembuatan Obat. 6 The ICH Quality Discussion Group (QDG) has recommended contemporizing the specification setting guidelines ICH Q6A and Q6B. Q6B. Geneva, 10 June 2021 The International Council for Harmonisation (ICH) met virtually on 2-3 June 2021 in place of face-to- face meetings that were to take place in Incheon, Republic of Korea. gov. 2 The Q4B Expert Working Group (EWG) In November 2003, ICH established the Q4B EWG to evaluate and recommend pharmacopoeial texts that are proposed for use in the three ICH regions. P 4. Q6A(ステップ5) 新医薬品の規格及び試験方法の設定(2001年5月1日) (原文)Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances . This chapter shows these trees. GUIDELINES 2. These proposed guidelines (Q2 and Q14) are intended to complement with ICH Q8 to Q12 Guidelines, as well as on-going ICH Q13 for Continuous Manufacturing. Since its inception in 1990, ICH has gradually evolved, to Jun 16, 2023 · ich q6b The principles adopted and explained in this document apply to proteins and polypeptides, their derivatives, and products of which they are components (e. dated 10 March 1999. This guidelines provides. While additional guidance has already been pub-lished for FIH small molecule specifications,3 there is currently no consensus guidance published for strategies in setting early-phase Dec 31, 2002 · Recent international harmonization efforts such as the International Conference on Harmonization (ICH) Harmonized Tripartite Guideline: Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances have provided general guidance for setting specifications for new drug substances and drug products, but have not provided procedure validation applicable to products mostly in the scope of Q6A and Q6B. Mit dieser Leitlinie über Spezifikationen für biotechnologische Produkte beabsichtigt die ICH (Japan, USA, EU) einheitliche Standards für die Spezifikationen biotechnologischer Produkte zu … harmonisation efforts at ICH meetings as appropriate. (Tel) 800-835-4709 or 301-827-1800. U. The ISPE Pharmaceutical Quality Lifecycle decision tree #4: investigating the need to set acceptance criteria for polymorphism in drug substances and drug products drug substance 1. Examples are provided to illustrate how the new method may be used to assist in setting specifications according to the recommendations in Q6A. This less than full schedule of testing should be justified and presented to the regulatory authority prior to implementation. Current Step 4 version . Jan 3, 2017 · ICH Leitlinien zur Qualität biotechnologischer Produkte hinsichtlich der Spezifikation von neuen biotechnologischen Substanzen. Like all ICH guidances, the primary objectives of ICH Q6A and Q6B are to bring harmoniza-tion across the member regions when setting specifications for pharmaceutical product registration and the mainte-nance of such registrations; however, given time and expe-rience, it is not unexpected to see some level of divergence the principles of risk management as described in ICH Q9. The guideline applies to new finished drug products (as defined in ICH Q6A and Q6B) and new drug products containing existing drug substances. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF Sep 22, 2021 · ICH基础知识500问 | 质量标准:生物制品的检验方法和验收标准. There are five stages in the ICH process for developing a new guideline (denoted a “major topic”), represented in Fig. Health & Medicine. e6_r1 Jan 1, 2013 · Particle characterization uses the International Conference on Harmonization's (ICH) Q6A guideline on specifications [9] is a useful starting point because it identifies potentially important The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. This approach applies equally for the ICH Q6B Maintenance, modernisation and targeted revision of the Q1/Q5C Stability guideline series and Q6A/Q6B 1 The ICH Quality Vision was issued in 2003 with the intent to “Develop a harmonised pharmaceutical quality system applicable across the lifecycle of the product emphasizing an integrated approach to quality risk management and science. ICH Jan 6, 2024 · ICH Q6B provides a comprehensive framework for establishing and evaluating these specifications to ensure the consistency and reliability of the final product. ” Sep 27, 2017 · The ICH Q6A guidance contains various decision trees aimed at helping applicants navigate the various courses of action necessary in establishing acceptance criteria. SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS. It addresses aspects of development and manufacture that pertain to drug substance, including the presence of steps designed to reduce impurities. Management Committee. Scope and Applicability. Examining the implications and practical implementation of multi-disciplinary International Conference on Harmonization (ICH) topics, this book gives an integrated view of how the guidelines inform drug development strategic planning and decision-making. The ICH process. Attachment 2 has been revised on 25 October 2006. 6 October 1999: Q6A Feb 7, 2016 · q6a Текущая версия (этап 4) q6a Одобрено Управляющим комитетом в качестве этапа 4 и передано трем уполномоченным органам ich на утверждение 6 октября 1999 г. The Q4B EWG anticipates that the PDG will be the principal source of pharmacopoeial text proposals. The guideline does not have any significant content of suggestions in the course of clinical research phases of drug development. Currently, endotoxin levels are strongly regulated and strictly tested for pharmaceutical products (ICH Q6A and Q6B Specifications, 1999 [33, 34]). COPE . The ICH specification guideline Q6A distinguishes between universal tests, which are required in any specification for a new DS or DP, and specific tests, which should be included, on a case-by-case basis, depending on or. , manufacturing capability and control methodology) can be considered as part of the justification for selection of alternative thresholds based on manufacturing experience with the proposed commercial process. This paper provides a new computational method for determining shelf life, expiry limits, and release limits using random slopes based upon Least Squares ANOVA Estimators. In addition, ICH Q11 provides further clarification on the principles and concepts described in ICH Guidelines on Pharmaceutical Development (Q8), Quality Risk Management (Q9) Sep 29, 2017 · ICH Q6A Specifications: An Implementation Guide. q6a drug products” [3]. Annex to the Tripartite ICH Guideline for the Stability Testing of New Drug Substances and Products ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 30 November 1995, this guideline is recommended for adoption to the three regulatory parties to ICH 1. The primary goal of a specification is to ensure patients receive a safe and Jan 24, 2024 · ICH Q6A and Q6B contain guidance on the principles for establishing product specifications that conflicts with the principles set forth in Q8(R2), as well as the supporting guidelines of ICH Q9, 27 International Committee for Harmonization. , Decision Tree #3 and #4 (Part 2)). q8(r2)_pharmaceutical development. Division of Drug Information, HFD-240. 1 General Principles The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines. neue Fertigarzneimittel zu ermöglichen Jan 1, 2020 · According to ICH Q6A 1 and Q6B, 2 a specification (singular) contains three components: a list of tests (or attributes), references to test methods, and acceptance criteria. 1. Jun 16, 2023 · As previously discussed in Chap. for the dosage form. The guideline applies to new finished drug products (as defined in ICH Q6A and Q6B) Specification Specification, which is a list of tests, reference to analytical procedures, and proposed acceptance criteria, including the concept of different acceptance criteria for release and shelf life specifications, is addressed in ICH Q6A and Q6B. The European Medicines Agency publishes scientific guidelines on human medicines that are harmonised by the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH Public Events. Home; The page is under construction! This guidance is intended to assist in the establishment of a single set of global specifications for new drug substances and new drug products. 12 stability workshop ich q6a c. The information provided should. Additional copies are available from: Office of Training and Communication. Human Regulatory and procedural guidance Research and development Scientific guidelines. ICH PQKM Task Force. mendations outlined in ICH Q6A and ICH Q6B. General Concepts 2. <a href=http://inilahkalbar.com/thsk4mf/delovi-za-imt-506-kupujemprodajem.html>sc</a> <a href=http://inilahkalbar.com/thsk4mf/cerita-stim-Ekin-1.html>gw</a> <a href=http://inilahkalbar.com/thsk4mf/love-marriage-images.html>vb</a> <a href=http://inilahkalbar.com/thsk4mf/cand-se-mananca-fructele.html>wu</a> <a href=http://inilahkalbar.com/thsk4mf/grupos-de-whatsapp-sin-reglas.html>ot</a> <a href=http://inilahkalbar.com/thsk4mf/1112-01-past-papers-with-answers-pdf-free-download.html>ra</a> <a href=http://inilahkalbar.com/thsk4mf/devotion-dramione.html>qd</a> <a href=http://inilahkalbar.com/thsk4mf/fm22-mobile-cheats.html>ok</a> <a href=http://inilahkalbar.com/thsk4mf/aafes-employee-handbook-2023-free.html>hk</a> <a href=http://inilahkalbar.com/thsk4mf/redmond-oregon-police-department.html>wj</a> </font></p> </div> </div> </div> </div> </div> </div> <div id="landingpage-bottom-section" class="landingpage-section bottom-section placeholder-section hide-section"> <div class="section-background"></div> <div class="section-content"></div> </div> </div> </div> </div> <div class="fr-dropdown-holder tcb-style-wrap"></div> </div> <div class="tvd-toast tve-fe-message" style="display: none;"> <div class="tve-toast-message tve-success-message"> <div class="tve-toast-icon-container"> <span class="tve_tick thrv-svg-icon"></span> </div> <div class="tve-toast-message-container"></div> </div> </div> <div style="display: none;" id="tve_thrive_lightbox_26"> <div class="tve_p_lb_overlay" data-style="" style=""></div> <div class="tve_p_lb_content bSe cnt tcb-lp-lb" style="" data-css="tve-u-167515c9e8e"> <div class="tve_p_lb_inner" id="tve-p-scroller" style=""><article></article> <div id="tve_flt" class="tve_flt tcb-style-wrap"> <div id="tve_editor" class="tve_shortcode_editor tar-main-content" data-post-id="26"> <div class="thrv_wrapper thrv_contentbox_shortcode thrv-content-box" data-tve-style="5" data-css="tve-u-167515ccca1"> <div class="tve-content-box-background" data-css="tve-u-167515ccca0"></div> <div class="tve_black tve-cb" style="border: 0px none transparent; background-color: transparent;"> <div class="tve_cb_cnt tve_empty_dropzone"> <div class="thrv_wrapper thrv_columns tve_clearfix" style="margin-top: 0pt; margin-bottom: 0pt;"> <div class="tve_colm tve_oth tve_empty_dropzone"> <div class="thrv_wrapper thrv_text_element"> <p> </p> </div> </div> <div class="tve_colm tve_tth tve_lst tve_empty_dropzone"> <div class="thrv_wrapper thrv-columns"> <div class="tcb-flex-row v-2 tcb--cols--1"> <div class="tcb-flex-col"> <div class="tcb-col"> <div class="thrv_wrapper thrv_text_element" data-tag="h3"> <h3 class="" style="color: rgb(51, 51, 51); font-size: 44px; margin-bottom: 0px;" data-css="tve-u-17306bfaa03"><span class="bold_text">Out of Water?</span> Fill out the form below for assistance</h3> </div> </div> </div> </div> </div> <div class="thrv_wrapper thrv_text_element" data-tag="h1"> <h1 class="" data-css="tve-u-16a5068edfe" style="text-align: center;"><strong>You will receive a response to your inquiries Monday - Friday between 10am and 4pm ONLY!</strong></h1> </div> </div> </div> </div> </div> </div> <div class="thrv-columns thrv_wrapper" style=""> <div class="tcb-flex-row tcb--cols--2"> <div class="c-33 tve_empty_dropzone tcb-flex-col"> <div class="tcb-col"> <div style="width: 245px;" class="thrv_wrapper tve_image_caption aligncenter knowhow-lightbox-image" data-css="tve-u-17306bfbe28"> <span class="tve_image_frame"> <img decoding="async" loading="lazy" class="tve_image" src="//" style="" data-attachment-id="24" data-width="245" data-height="476" data-init-width="245" data-init-height="476" height="476" width="245"> </span> </div> </div> </div> <div class="c-66 tve_empty_dropzone tcb-flex-col"> <div class="tcb-col"> <div class="thrv_wrapper thrv_text_element"> <p class="tve_p_left" style="color: rgb(102, 102, 102); font-size: 16px; margin-top: 0px ! important; margin-bottom: 0px;">*Please Allow 48-72 hours for delivery</p> <p style="color: rgb(102, 102, 102); font-size: 16px; margin-top: 0pt; margin-bottom: 0pt;">*By leaving your cell phone number, you are giving us permission to call you</p> <p style="color: rgb(102, 102, 102); font-size: 16px; margin-top: 0px; margin-bottom: 0px;">Emergency water service<br> </p> <p style="color: rgb(102, 102, 102); font-size: 16px; margin-top: 0pt; margin-bottom: 0pt;"><span class="tve_custom_font_size" style="font-size: 12px;">*A fuel charge may apply to delivery</span></p> </div> <div class="thrv_wrapper thrv_custom_html_shortcode" style="margin-bottom: -25px ! important; margin-top: 0px ! important;"><iframe title="Embedded Wufoo Form" allowtransparency="true" style="border: medium none ; width: 100%;" src="" frameborder="0" height="908" scrolling="no"> <a> Fill out my Wufoo form! </a> </iframe> <div class="tve_iframe_cover"></div> </div> </div> </div> </div> </div> </div> </div> <div class="tcb_flag" style="display: none;"></div> <span id="tho-end-content" style="display: block; visibility: hidden;"></span></div> <a href="javascript:void(0)" class="tve_p_lb_close" style="" data-css="tve-u-167515c9e9b" title="Close">x</a></div> </div> <div style="display: none;" id="tve_thrive_lightbox_22"> <div class="tve_p_lb_overlay" data-style="" style="" data-css="tve-u-17306c05ff5"></div> <div class="tve_p_lb_content bSe cnt tcb-lp-lb" style="" data-css="tve-u-17306c06005"> <div class="tve_p_lb_inner" id="tve-p-scroller" style=""><article></article> <div id="tve_flt" class="tve_flt tcb-style-wrap"> <div id="tve_editor" class="tve_shortcode_editor tar-main-content" data-post-id="22"> <div class="thrv_wrapper thrv_contentbox_shortcode" data-tve-style="5"> <div class="tve_cb tve_cb5 tve_black"> <div class="tve_cb_cnt tve_empty_dropzone"> <div class="thrv_wrapper thrv_text_element" data-tag="h3"> <h3 class="" style="color: rgb(51, 51, 51); font-size: 44px; margin-bottom: 0px;" data-css="tve-u-179f71b3ada"><span class="bold_text">Billing Questions?</span> <br> Please fill out the form below for assistance</h3> </div> <div class="thrv_wrapper thrv_text_element" data-tag="h1"> <h1 class="" data-css="tve-u-16a506a4081" style="text-align: center;"><strong>You will receive a response to your inquiries Monday - Friday between 10am and 4pm ONLY!</strong></h1> </div> <div class="thrv_wrapper thrv_columns tve_clearfix" style="margin-top: 0pt; margin-bottom: 0pt;"> <div class="tve_colm tve_oth tve_empty_dropzone"> </div> <div class="tve_colm tve_tth tve_lst tve_empty_dropzone"></div> </div> </div> </div> </div> <div class="thrv_wrapper thrv_custom_html_shortcode" style="margin-bottom: 0px ! important;"><iframe title="Embedded Wufoo Form" allowtransparency="true" style="border: medium none ; width: 100%;" src="" frameborder="0" height="996" scrolling="no"> <a> Fill out my Wufoo form! </a> </iframe> <div class="tve_iframe_cover"></div> </div> </div> </div> <div class="tcb_flag" style="display: none;"></div> <span id="tho-end-content" style="display: block; visibility: hidden;"></span></div> <a href="javascript:void(0)" class="tve_p_lb_close" style="" data-css="tve-u-17306c0600f" title="Close">x</a></div> </div> <div style="display: none;" id="tve_thrive_lightbox_31"> <div class="tve_p_lb_overlay" data-style="" style=""></div> <div class="tve_p_lb_content bSe cnt tcb-lp-lb" style="" data-css="tve-u-17306bf1ef1"> <div class="tve_p_lb_inner" id="tve-p-scroller" style=""><article></article> <div id="tve_flt" class="tve_flt tcb-style-wrap"> <div id="tve_editor" class="tve_shortcode_editor tar-main-content" data-post-id="31"> <div class="thrv_wrapper thrv_contentbox_shortcode thrv-content-box" data-tve-style="5" data-css="tve-u-17306bed0c2"> <div class="tve-content-box-background" data-css="tve-u-17306bed0c0"></div> <div class="tve_black tve-cb" style="border: 0px none transparent; background-color: transparent;"> <div class="tve_cb_cnt tve_empty_dropzone"> <div class="thrv_wrapper thrv_columns tve_clearfix" style="margin-top: 0pt; margin-bottom: 0pt;"> <div class="tve_colm tve_oth tve_empty_dropzone"> <div class="thrv_wrapper thrv_text_element"> <p> </p> </div> </div> <div class="tve_colm tve_tth tve_lst tve_empty_dropzone"> <div class="thrv_wrapper thrv_text_element"> <h3 class="" style="color: rgb(51, 51, 51); font-size: 44px; margin-bottom: 0px;" data-css="tve-u-17306bf5c1b">Leaking Bottle? Here is how to check your bottle for leaks:</h3> </div> </div> </div> </div> </div> </div> <div class="thrv-columns thrv_wrapper" style=""> <div class="tcb-flex-row tcb-resized tcb--cols--2"> <div class="c-33 tve_empty_dropzone tcb-flex-col" data-css="tve-u-17306bdd200" style=""> <div class="tcb-col"> <div style="" class="thrv_wrapper tve_image_caption aligncenter knowhow-lightbox-image" data-css="tve-u-17306bdf9cc"> <span class="tve_image_frame"> <img decoding="async" loading="lazy" class="tve_image" src="//" style="" data-attachment-id="24" data-width="268" data-height="521" data-init-width="267" data-init-height="435" data-css="tve-u-17306bdf9db" height="521" width="268"> </span> </div> <div class="thrv_wrapper thrv_custom_html_shortcode"><iframe title="Embedded Wufoo Form" allowtransparency="true" style="border: medium none ; width: 100%;" src="" frameborder="0" height="1500" scrolling="no"> <a>Fill out my Wufoo form!</a> </iframe> <div class="tve_iframe_cover"></div> </div> </div> </div> <div class="c-66 tve_empty_dropzone tcb-flex-col" data-css="tve-u-17306bdd219" style=""> <div class="tcb-col"> <div class="thrv_responsive_video thrv_wrapper" data-url="" data-modestbranding="1" data-aspect-ratio="16:9" style="" data-float="false" data-overlay="0" data-type="youtube" data-rel="0" data-aspect-ratio-default="0" data-float-visibility="mobile" data-float-position="top-left" data-float-width-d="300px" data-float-padding1-d="25px" data-float-padding2-d="25px"> <div class="tve_responsive_video_container" style=""> <div class="tcb-video-float-container"><iframe title="Responsive Video" class="tcb-responsive-video" data-code="94yJEhoo6Pw" data-provider="youtube" allowfullscreen="" data-src=" class=" video_overlay="" frameborder="0"></div></div> </div> </div><div><span><img></span></div></div> </div> </div></div></div></div><div></div><span></span></article></div><a>x</a></div></div><style>@media (min-width:300px){[data-css="tve-u-1675161f432"]{background-color:rgb(226,226,226);border:0px none rgb(51,51,51);border-radius:0px;}[data-css="tve-u-1675161f435"]{padding:0px;}[data-css="tve-u-1675161f435"] .tve-cb h3{color:rgb(51,51,51);margin-top:60px;margin-bottom:0px;}[data-css="tve-u-1675161f435"] .tve-cb p{color:rgb(255,255,255);margin-top:0px;margin-bottom:24px;}[data-css="tve-u-1675163f6cd"]{z-index:0;margin-top:-227px !important;}:not(#tve) [data-css="tve-u-16a506c8f37"]{color:rgb(255,0,0) !important;text-transform:uppercase !important;font-size:23px !important;}:not(#tve) [data-css="tve-u-17306c0a2e8"]{padding-top:0px !important;margin-top:0px !important;}[data-css="tve-u-17306c0ab06"]{max-width:1000px !important;border-style:none !important;background-color:rgb(255,255,255) !important;border-color:rgb(51,51,51) !important;}[data-css="tve-u-17306c0ab13"]{border-style:inherit !important;background-color:rgba(0,0,0,0) !important;border-color:rgb(98,98,98) !important;color:rgb(98,98,98) !important;border-width:inherit !important;display:none !important;}}</style><div><div></div><div><div><article><div><div><div><div></div> <div> <div> <div> <div> <div><p>&nbsp;</p></div> </div> <div> <div><h3><span>Having other issues?</span> Fill out this form <span>below</span> for assistance.</h3></div><div><h1><strong>You will receive a response to your inquiries Monday - Friday between 10am and 4pm ONLY!</strong></h1></div> </div> </div> </div> </div> </div> <div><div> <div> <div><div> <span> <img> </span> </div></div> </div> <div> <div><div><iframe> <a> Fill out my Wufoo form! </a> </iframe> <div class="tve_iframe_cover"></div> </div> </div> </div> </div> </div> </div> </div> <div class="tcb_flag" style="display: none;"></div> <span id="tho-end-content" style="display: block; visibility: hidden;"></span></div> <a href="javascript:void(0)" class="tve_p_lb_close" style="" data-css="tve-u-17306c0ab13" title="Close">x</a></div> </div> <div style="display: none;" id="tve_thrive_lightbox_12"> <div class="tve_p_lb_overlay" data-style="" style=""></div> <div class="tve_p_lb_content bSe cnt tcb-lp-lb" style="" data-css="tve-u-17da6e42eef"> <div class="tve_p_lb_inner" id="tve-p-scroller" style=""><article></article> <div id="tve_flt" class="tve_flt tcb-style-wrap"> <div id="tve_editor" class="tve_shortcode_editor tar-main-content" data-post-id="12"> <div class="thrv_wrapper thrv-columns" style=""> <div class="tcb-flex-row v-2 tcb--cols--2" data-css="tve-u-17da6e4d916" style=""> <div class="tcb-flex-col c-33"> <div class="tcb-col"> <div class="thrv_wrapper tve_image_caption" data-css="tve-u-17da6e4b51c"><span class="tve_image_frame"><a href=""><img decoding="async" class="tve_image wp-image-29" alt="" data-id="29" data-init-width="267" data-init-height="435" title="slider1" loading="lazy" src="" data-width="267" data-height="435" data-link-wrap="true" srcset=" 267w, 184w" sizes="(max-width: 267px) 100vw, 267px" height="435" width="267"></a></span></div> </div> </div> <div class="tcb-flex-col c-66" data-css="tve-u-17db5a38c01" style=""> <div class="tcb-col"> <div class="thrv_wrapper thrv_custom_html_shortcode"><iframe title="Embedded Wufoo Form" allowtransparency="true" style="border: medium none ; width: 100%;" src="" frameborder="0" height="1275" scrolling="no"> <a>Fill out my Wufoo form!</a> </iframe> <div class="tve_iframe_cover"></div> </div> </div> </div> </div> </div> </div> </div> <div class="tcb_flag" style="display: none;"></div> <span id="tho-end-content" style="display: block; visibility: hidden;"></span></div> <a href="javascript:void(0)" class="tve_p_lb_close" style="" data-css="tve-u-17da6e42ef5" title="Close">x</a></div> </div> </div> </div> </body> </html>
/home/sudancam/public_html/0d544/../../.trash/./catalog/../../public_html/assets/../un6xee/index/ich-q6a-and-q6b.php